Valsartan Suppresses an Increase in Urinary Catecholamines and Arrhythmias in a Patient with Hypertension

Accession number;05A0587728
Title;Valsartan Suppresses an Increase in Urinary Catecholamines and Arrhythmias in a Patient with Hypertension
Author; HAYASHIDA KYOKO (Nagasaki Univ. Graduate School Of Biomedical Sci., Nagasaki, Jpn) KAWANO HIROAKI (Nagasaki Univ. Graduate School Of Biomedical Sci., Nagasaki, Jpn) TODA GENJI (Nagasaki Univ. Graduate School Of Biomedical Sci., Nagasaki, Jpn) YANO KATSUSUKE (Nagasaki Univ. Graduate School Of Biomedical Sci., Nagasaki, Jpn)
Journal Title;Acta Med Nagasaki Ensia
Journal Code:X0952A
ISSN:0001-6055
VOL.50;NO.2;PAGE.77-78(2005)
Figure&Table&Reference;TBL.1, REF.13
Pub. Country;Japan
Language;English
Abstract;We report a case of a 64-year-old woman with hypertension. She had dizziness and palpitation without heart failure although she was taking amlodipine. Urine levels of epinephrine and norepinephrine were high and both atrial and ventricular premature contraction were frequently seen. Valsartan, angiotensin II type 1 receptor antagonist, decreased these catecholamine levels and suppressed arrhythmias in the present case without the use of other drugs such as beta-blockers or anti-arrhythmic agents. In conclusion, valsartan is one option that can be used to prevent arrhythmias as well as to control blood pressure in hypertensive patients. (author abst.)
FULLTEXT